Higher habitual flavonoid intakes are associated with a lower risk of peripheral artery disease hospitalizations.

cohort study lifestyle nutrition peripheral artery disease primary prevention

Journal

The American journal of clinical nutrition
ISSN: 1938-3207
Titre abrégé: Am J Clin Nutr
Pays: United States
ID NLM: 0376027

Informations de publication

Date de publication:
04 Jan 2021
Historique:
received: 20 01 2020
accepted: 30 09 2020
pubmed: 26 11 2020
medline: 26 11 2020
entrez: 25 11 2020
Statut: ppublish

Résumé

The role of nutrition in the primary prevention of peripheral artery disease (PAD), the third leading cause of atherosclerotic cardiovascular disease, is undetermined. Flavonoids may attenuate atherosclerosis and therefore persons who consume flavonoid-rich foods may have a lower risk of developing PAD. We aimed to examine the association between flavonoid intake and PAD hospitalizations and investigate if the association differs according to established risk factors for PAD. Baseline data from 55,647 participants of the Danish Diet, Cancer, and Health Study without PAD, recruited from 1993 to 1997, were cross-linked with Danish nationwide registries. Flavonoid intake was calculated from FFQs using the Phenol-Explorer database. Associations were examined using multivariable-adjusted restricted cubic splines based on Cox proportional hazards models. After a median [IQR] follow-up time of 21 [20-22] y, 2131 participants had been hospitalized for any PAD. The association between total flavonoid intake and total PAD hospitalizations was nonlinear, reaching a plateau at ∼750-1000 mg/d. Compared with the median flavonoid intake in quintile 1 (174 mg/d), an intake of 1000 mg/d was associated with a 32% lower risk of any PAD hospitalization (HR: 0.68; 95% CI: 0.60, 0.77), a 26% lower risk of atherosclerosis (HR: 0.74; 95% CI: 0.62, 0.88), a 28% lower risk of an aneurysm (HR: 0.72; 95% CI: 0.59, 0.88), and a 47% lower risk of a hospitalization for other peripheral vascular disease (HR: 0.53; 95% CI: 0.42, 0.67). A higher total flavonoid intake was also significantly associated with a lower incidence of revascularization or endovascular surgery and lower extremity amputation. The association between total flavonoid intake and PAD hospitalizations differed according to baseline smoking status, alcohol intake, BMI, and diabetes status. Ensuring the adequate consumption of flavonoid-rich foods, particularly in subpopulations prone to the development of atherosclerosis, may be a key strategy to lower the risk of PAD.

Sections du résumé

BACKGROUND BACKGROUND
The role of nutrition in the primary prevention of peripheral artery disease (PAD), the third leading cause of atherosclerotic cardiovascular disease, is undetermined. Flavonoids may attenuate atherosclerosis and therefore persons who consume flavonoid-rich foods may have a lower risk of developing PAD.
OBJECTIVES OBJECTIVE
We aimed to examine the association between flavonoid intake and PAD hospitalizations and investigate if the association differs according to established risk factors for PAD.
METHODS METHODS
Baseline data from 55,647 participants of the Danish Diet, Cancer, and Health Study without PAD, recruited from 1993 to 1997, were cross-linked with Danish nationwide registries. Flavonoid intake was calculated from FFQs using the Phenol-Explorer database. Associations were examined using multivariable-adjusted restricted cubic splines based on Cox proportional hazards models.
RESULTS RESULTS
After a median [IQR] follow-up time of 21 [20-22] y, 2131 participants had been hospitalized for any PAD. The association between total flavonoid intake and total PAD hospitalizations was nonlinear, reaching a plateau at ∼750-1000 mg/d. Compared with the median flavonoid intake in quintile 1 (174 mg/d), an intake of 1000 mg/d was associated with a 32% lower risk of any PAD hospitalization (HR: 0.68; 95% CI: 0.60, 0.77), a 26% lower risk of atherosclerosis (HR: 0.74; 95% CI: 0.62, 0.88), a 28% lower risk of an aneurysm (HR: 0.72; 95% CI: 0.59, 0.88), and a 47% lower risk of a hospitalization for other peripheral vascular disease (HR: 0.53; 95% CI: 0.42, 0.67). A higher total flavonoid intake was also significantly associated with a lower incidence of revascularization or endovascular surgery and lower extremity amputation. The association between total flavonoid intake and PAD hospitalizations differed according to baseline smoking status, alcohol intake, BMI, and diabetes status.
CONCLUSIONS CONCLUSIONS
Ensuring the adequate consumption of flavonoid-rich foods, particularly in subpopulations prone to the development of atherosclerosis, may be a key strategy to lower the risk of PAD.

Identifiants

pubmed: 33236045
pii: S0002-9165(22)00572-X
doi: 10.1093/ajcn/nqaa300
pmc: PMC7779235
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

187-199

Subventions

Organisme : Danish Heart Foundation
ID : 17-R115-A7443-22062
Organisme : Gangstedfonden
ID : A35136
Organisme : National Health and Medical Research Council
ID : APP1159914
Organisme : Danish Diet, Cancer, and Health Study
Organisme : Danish Cancer Society
Organisme : International Agency for Research on Cancer
Organisme : WHO

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the American Society for Nutrition.

Auteurs

Nicola P Bondonno (NP)

School of Medical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia.
School of Biomedical Sciences, University of Western Australia, Perth, Western Australia, Australia.
Institute for Global Food Security, Queen's University Belfast, Belfast, United Kingdom.

Kevin Murray (K)

School of Population and Global Health, University of Western Australia, Perth, Western Australia, Australia.

Aedin Cassidy (A)

Institute for Global Food Security, Queen's University Belfast, Belfast, United Kingdom.

Catherine P Bondonno (CP)

School of Medical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia.
School of Biomedical Sciences, University of Western Australia, Perth, Western Australia, Australia.

Joshua R Lewis (JR)

School of Medical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia.
School of Biomedical Sciences, University of Western Australia, Perth, Western Australia, Australia.

Kevin D Croft (KD)

School of Biomedical Sciences, University of Western Australia, Perth, Western Australia, Australia.

Cecilie Kyrø (C)

The Danish Cancer Society Research Centre, Copenhagen, Denmark.

Gunnar Gislason (G)

Department of Cardiology, Herlev & Gentofte University Hospital, Copenhagen, Denmark.
The National Institute of Public Health, University of Southern Denmark, Odense, Denmark.
The Danish Heart Foundation, Copenhagen, Denmark.

Christian Torp-Pedersen (C)

Department of Clinical Investigation and Cardiology, Nordsjælland Hospital, Hillerød, Denmark.

Augustin Scalbert (A)

International Agency for Research on Cancer, Lyon, France.

Anne Tjønneland (A)

The Danish Cancer Society Research Centre, Copenhagen, Denmark.
Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Jonathan M Hodgson (JM)

School of Medical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia.
School of Biomedical Sciences, University of Western Australia, Perth, Western Australia, Australia.

Frederik Dalgaard (F)

Department of Cardiology, Herlev & Gentofte University Hospital, Copenhagen, Denmark.

Classifications MeSH